Evaluation of Methods for Estimating Time to Steady State with Examples from Phase 1 Studies

Por Maganti, Lata, Panebianco, Deborah L., Maes, Andrea L.
Publicado em 2008

The Dose Proportionality of Telcagepant after Administration of Single Oral and Intravenous Doses in Healthy Adult Subjects

Por Han, Tae H, Blanchard, Rebecca L, Palcza, John, Martucci, Ashley, Miller-Stein, Cynthia M, Gutierrez, Maria, Panebianco, Deborah, Rippley, Ronda K, Lines, Christopher, Murphy, M Gail
Publicado em 2010

Odanacatib, a selective cathepsin K inhibitor to treat osteoporosis: safety, tolerability, pharmacokinetics and pharmacodynamics – results from single oral dose studies in healthy...

Por Stoch, S Aubrey, Zajic, Stefan, Stone, Julie A, Miller, Deborah L, Bortel, Lucas, Lasseter, Kenneth C, Pramanik, Barnali, Cilissen, Caroline, Liu, Qi, Liu, Lida, Scott, Boyd B, Panebianco, Deborah, Ding, Yu, Gottesdiener, Keith, Wagner, John A
Publicado em 2013

Effect of Hepatic Impairment on the Pharmacokinetics of Grazoprevir, a Hepatitis C Virus Protease Inhibitor

Por Caro, Luzelena, Wenning, Larissa, Guo, Zifang, Fraser, Iain P., Fandozzi, Christine, Talaty, Jennifer, Panebianco, Deborah, Ho, Maureen, Uemura, Naoto, Reitmann, Christina, Angus, Peter, Gane, Edward, Marbury, Thomas, Smith, William B., Iwamoto, Marian, Butterton, Joan R., Yeh, Wendy W.
Publicado no Antimicrob Agents Chemother (2017)

Single-dose pharmacokinetics and pharmacodynamics of anacetrapib, a potent cholesteryl ester transfer protein (CETP) inhibitor, in healthy subjects

Por Krishna, Rajesh, Garg, Amit, Panebianco, Deborah, Cote, Josee, Bergman, Arthur J, Van Hoydonck, Pascale, Laethem, Tine, Van Dyck, Kristien, Chen, Jingjing, Chavez-Eng, Cynthia, Archer, Laura, Lutz, Ryan, Hilliard, Deborah, Snyder, Karen, Jin, Bo, Van Bortel, Luc, Lasseter, Kenneth C, Al-Huniti, Nidal, Dykstra, Kevin, Gottesdiener, Keith, Wagner, John A
Publicado em 2009